跳至主要内容
临床试验/NL-OMON20373
NL-OMON20373招募中不适用

Severe Asthma with comorbid BronchiEctasis: response to BIOlogical therapy

o0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
o
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Dutch adult (>18 yr) included in RAPSODI
  • - Received at least 1 dose of one of the anti-IL-5 treatments (mepolizumab, reslizumab, benralizumab).
  • - Anti- IL-5 treatment was started before 1.9.2020
  • - Data on presence or absence of BE (reported comorbidity and CT-scan) are available

排除标准

  • Not applicable

研究者

发起方
o

相似试验